Abstract：ObjectiveTo investigate the clinical effect of Cefoperazone/Sulbactam combined with Moxifloxacin Hydrochloride in the treatment of severe pneumonia.Methods108 patients with severe pneumonia diagnosed and treated in our hospital from February 2014 to January 2017 were divided into control group (50 cases)and Moxifloxacin Hydrochloride combined with Cefoperazone/Sulbactam group (58 cases)according to the different treatment measures.The inflammation index,white blood cell count and clinical efficacy of the two groups of patients with severe pneumonia before and after treatment were observed.ResultsThere was no significant difference in PCT,WBC and CRP between the two groups before treatment(P＜0.05).After treatment,the levels of PCT,WBC and CRP in the control group and Cefoperazone/Sulbactam combined Moxifloxacin Hydrochloride group were lower than those before treatment(P＜0.05).After treatment,the levels of PCT,WBC and CRP in Cefoperazone/Sulbactam combined Moxifloxacin Hydrochloride group were lower than those in the control group(P＜0.05).The total effective rate of Cefoperazone/Sulbactam combined with Moxifloxacin Hydrochloride group was higher than that of the control group(P＜0.05).ConclusionIn the treatment of severe pneumonia patients,Cefoperazone/Sulbactam combined with Moxifloxacin Hydrochloride greatly improves the clinical symptoms in a favorable effect,which is worthy of clinical application and promotion.
李雪平; 黄国华; 古 辉; 杜燕芳. 头孢哌酮/舒巴坦联合盐酸莫西沙星治疗重症肺炎的临床效果[J]. 中国当代医药, 2018, 25(6): 87-89.
LI Xue-ping; HUANG Guo-hua; GU Hui;DU Yan-fang. Clinical effect of Cefoperazone/Sulbactam combined with Moxifloxacin Hydrochloride in the treatment of severe pneumonia. 中国当代医药, 2018, 25(6): 87-89.
Mogami R，Goldenberg T，de Marca PG，et al.Pulmonary infection caused by Mycobacterium kansasii：findings on computed tomography of the chest[J].Radiol Bras，2016，49（4）：209-213.
[2]
He GL，Chang YJ，Xu LP，et al.Impact of pre-transplant pulmonary infection developed in horizontal laminar flow unit on the outcome of subsequent allogeneic hematopoietic stem cell transplantation[J].J Thorac Dis，2016，8（8）：2219-2225.
[3]
Ramsay KA，Sandhu H，Geake JB，et al.The changing prevalence of pulmonary infection in adults with cystic fibrosis：A longitudinal analysis[J].J Cyst Fibros，2016，3（16）： 30567.
[4]
Haste L，Hulland K，Bolton S，et al.Development and characterization of a long-term murine model of Streptococcus pneumoniae infection of the lower airways[J].Infect Immun，2014，82（8）：3289-3298.
Virchow JC，Rodriguez-Roisin R，Papi A，et al.A randomized，double blinded，double-dummy efficacy and safety study of budesonide-for-moterol Spiromax compared to budesonideformoterolTurbuhalerinadultsandadolescentswithpersistent asthma[J].BMC Pulm Med，2016，17（16）：42.
京公网安备 11010502046607号